Roth Capital Maintains Buy on MaxLinear, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 76.9%

Neg 0% Neu 0% Pos 76.9%

Roth Capital analyst Suji Desilva maintains MaxLinear (NASDAQ:MXL) with a Buy and raises the price target from $60 to $100.